MAIA's CEO and a director each buy $100,000 of its shares
MAIA Biotechnology's chief executive Vlad Vitoc and director Stan Smith each bought 100,000 shares at $1.00 on November 13 and 16, as declared on November 17.
The purchases
2 insiders
Purchase on Nov 16, filed on Nov 17
2
Buyers
$200k
Bought
0
Sellers
Chief executive
VV
Vlad Vitoc
Buy · $100k · 100,000 shares
+9.5%
Director
SS
Stan Smith
Buy · $100k · 100,000 shares
+6.6%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.
AI analysis
Nov 17
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.